Scientific Committee

[View] Bruno FALISSARD Université Paris Sud
Marisa BACCHI Actelion
[View] Luc BIJNENS Johnson and Johnson
[View] Frank BRETZ Novartis
[View] Antoine CHAMBAZ Université Paris Ouest
[View] Jelle GOEMAN LUMC
Martin POSCH Medical University of Vienna

After some initial training in mathematics and fundamental physics (Ecole Polytechnique, Paris), Pr. Falissard engaged in medical studies and specialized in Psychiatry in 1991. His PhD was in biostatistics and his post doc in psychometrics and exploratory multimensional methods. He was assistant professor in child and adolescent psychiatry in 1996-1997, associate professor in Biostatistics in 1997-2002 and full professor in Biostatistics from 2002.
He is at the head of the Master in Public Health of South-Paris University (600 students) and at the head of the “Center of Epidemiology and Population Health” (450 members).
He is co-author of about 400 papers and author of 4 books. He has been a member of the “commission de la transparence” (French national institution for the reimbursement of medications). He has a clinical activity in child and adolescent psychiatry. His personal areas of research are about methodology and epistemology of biomedical research.
Since 2015 he is a member of the French Academy of Medicine.
Antoine Chambaz is professor of statistics at Université Paris Nanterre, France, where he chairs the applied mathematics department Modal'X.
His research interests are in targeted learning and reinforcement learning, with applications to medicine and public health. For a few years, he has been developing new methods and analyses for online dynamic resources allocation problems, with a special interest in the statistical analysis of targeted, sequential (possibly controlled) experiments and precision medicine.
He is one of the editors of The International Journal of Biostatistics, and serves as associate editor of The Journal of Causal Inference and The Scandinavian Journal of Statistics.

Frank Bretz joined Novartis in 2004, where he is currently Global Head of the Statistical Methodology and Consulting group. Frank has a keen interest in advancing practices of drug development.
He has supported the methodological development in various areas of pharmaceutical statistics, including dose finding, multiple comparisons, and adaptive designs. Frank is currently holding Adjunct/Guest professorial positions at the Hannover Medical School (Germany), Shanghai University of Finance and Economics (P.R. China), Medical University of Vienna (Austria) and Osaka University (Japan).
Among other professional services, he is a co-founding editor of the Springer Series in Pharmaceutical Statistics and the editor of Statistics in Biopharmaceutical Research.
He has authored or co-authored more than 120 articles in peer-reviewed journals and four books. Frank is a Novartis Distinguished Scientist, a recipient of the Susanne-Dahms-Medal from the German Region of the International Biometric Society and a Fellow of the American Statistical Association.
Jelle Goeman is professor of biostatistics at Leiden University Medical Center in the Netherlands. His research interests are high-dimensional data and (multiple) hypothesis testing, with applications in genomics and brain imaging.
He has developed global tests and methods for penalized regression for high-dimensional data. Recently, he works on flexible methods for post-selection inference.
Luc Bijnens is leading the “Global Discovery Statistics” team in the Statistics Department of Janssen Pharmaceutical Companies of Johnson and Johnson. The main areas of expertise of the group are in experimental design and the development of statistical methods and software to support pharmaceutical research and development.
Luc held positions in statistics at the European Organisation of treatment of Cancer, Bristol-Myers Squibb and as resident associate professor at the University of Kinsangani (DRC) before he joined J&J. He has been actively involved in the boards of the Three-Country-Corner local group of the British Royal Statistics Society and the Belgian Statistics Society. He is past president of the Quetelet Society and founding member of the Channel Network that are both units within the International Biometrics Society.
Over the last 20 years Luc has supervised master students and PhD students for their thesis in biostatistics at the University of Hasselt where he is teaching a course on statistical consulting since 2008. In May 2013 he won the first ever FLAMES award for ambassadorship of statistics in Flanders (BE). In September 2016 the European Network of Business and Industry Statistics awarded him the "manager of the year” award during the annual conference in Sheffield (UK).
Luc received his MSc in Statistics at Hasselt University (BE) and his PhD in Biology at the University of Antwerp (BE).

Stefan Michiels is Head of the Oncostat Team, INSERM U1018, University Paris-Saclay, University Paris-Sud, Gustave Roussy, Villejuif, France. His areas of expertise are statistical analysis of biomarker and genomic data, prognostic models, clinical trials, independent data monitoring committees and meta-analyses in oncology.
Stefan holds a PhD in Biostatistics from the School of Public Health at the Paris XI University and Master Degrees in Statistics and in Applied Mathematics from the University of Leuven.
His previous positions include the Université Libre de Bruxelles- Institut Jules Bordet (FNRS researcher), the National Cancer Institute (France) and the University of Leuven (Belgium).
He has authored above 130 peer-reviewed publications ( or in journals such as Lancet, JAMA, Lancet Oncology, NEJM, Journal of Clinical Oncology, Statistics in Medicine, Bioinformatics and Statistical Methods in Medical Research. He is member of the editorial board of JNCI, Annals of Oncology and Cancer Prevention Research.
Pascale Tubert-Bitter is Director of Research at the French National Institute of Health and Medical Research (Inserm) and head of the research unit « Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases ». She has a PhD in Mathematics from the Pierre and Marie Curie University in Paris. Her research interests concern the statistical methods to assess treatment effects, mainly in two areas pertaining to adverse drug reaction risks: automated signal detection from large pharmacovigilance databases and methodological issues raised by the growing access to medico-administrative databases in pharmacoepidemiology. Pascale Tubert-Bitter serves as an expert at the French Medicine Agency in the Epidemiological studies of health products working group. She is co-responsible of the Biostatistics specialty of the master Research in Public Health (Paris South – Paris Descartes Universities). She is also Secretary of the French Region of the International Biometric Society (IBS), Chair of the IBS-Education Committee, and elected member since 2006 of the Biopharmacy and Health Group board of the French Statistical Society.